Why did GAAP EPS fall so sharply when segment profits rose?

Segment adjusted EBIT rose, but several items weighed on reported results: higher Corporate and Other costs tied largely to the Viterra integration, a $118 million pension settlement loss, a $30 million impairment on long-term investments, a $15 million credit loss reserve, and higher interest expense of $628 million vs. $471 million. The 2025 gain on the corn milling divestiture (about $155 million) partly offset these, but the much larger share count also reduced per-share earnings.

What does the 2026 guidance imply for investors?

Bunge guided to 2026 adjusted EPS of $7.50 to $8.00, which is roughly flat to modestly down from the $7.57 adjusted EPS reported for 2025 at the midpoint of the range. The guidance is based on current margins and forward curves, and management noted that forward visibility remains limited. Investors should watch for synergy targets and capital allocation details at the March 10, 2026 Investor Day.

Why did operating cash flow decline even though Adjusted FFO increased?

Reported operating cash flow fell to $844 million from $1,900 million mainly because of lower reported net income and working capital changes, including higher inventories (up $700 million in cash-flow terms) and receivables. Adjusted FFO excludes working capital changes, FX on net debt, and mark-to-market timing differences, so it rose to $1,733 million, but it is a non-GAAP measure and investors should weigh the reported cash decline.

How has Bunge's balance sheet changed after the Viterra combination?

Total assets rose to $44,528 million from $24,899 million, driven by a larger PP&E base ($11,678 million), inventories ($13,198 million), and goodwill and intangibles ($3,450 million). Total debt increased significantly, and cash declined to $1,135 million. Total equity grew to $17,369 million, partly reflecting the share issuance tied to the combination, and the company's leverage and liquidity position is now materially different from a year ago.

What are the main risks highlighted in this release?

The release flags weather and crop disease, commodity and freight price volatility, trade and tariff policy, biofuels regulation, geopolitical risks including the Ukraine-Russia war and sanctions, execution risk in integrating Viterra and capturing synergies, and foreign exchange. Management also noted that market conditions make near-term visibility limited, and the company refers investors to Item 1A of its 10-K for a fuller discussion.

BG 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed February 4, 2026. Cited figures are marked; the original filing is the authoritative source.

Bunge Global SA (NYSE: BG) reported fourth-quarter and full-year 2025 results on February 4, 2026.

The headline story is a sharp drop in GAAP earnings, but the underlying picture is more mixed. Full-year GAAP diluted EPS fell to $4.93^a from $7.99, and adjusted EPS (excluding mark-to-market timing differences and certain gains/charges) fell to $7.57 from $9.19. Q4 GAAP EPS was $0.49 versus $4.36 a year earlier, and Q4 adjusted EPS was $1.99 versus $2.13.

Segment-level results were stronger: adjusted Segment EBIT rose to $2,459 million^b from $2,335 million for the year, and Q4 adjusted Segment EBIT rose to $756 million from $546 million. The gap between the segment improvement and the EPS decline is driven by higher corporate costs (largely Viterra integration), higher interest expense, a $118 million pension settlement loss, and a larger share count following the Viterra combination, which lifted diluted weighted-average shares to 195 million in Q4 from 138 million. Balance sheet and cash flow indicators show increased leverage and lower cash generation.

Operating cash flow fell to $844 million^c from $1,900 million, though Adjusted FFO rose modestly to $1,733 million from $1,682 million. Total debt rose meaningfully: short-term debt increased to $3,883 million and long-term debt to $8,831 million, while cash fell to $1,135 million from $3,311 million. Inventories grew to $13,198 million, including $11,361 million of readily marketable inventories, and goodwill and intangibles expanded to $3,450 million from $774 million.

Management said forward visibility remains limited. For 2026, Bunge guided to adjusted EPS of $7.50 to $8.00^d, with net interest expense of $575 to $625 million, capital expenditures of $1.5 to $1.7 billion, D&A of about $975 million, and an adjusted tax rate of 23% to 27%. Management will provide more detail on long-term outlook, synergy capture, and capital allocation at its Investor Day on March 10, 2026.

02—Key points

Key Highlights

Full-year GAAP diluted EPS of $4.93 vs. $7.99 in 2024; adjusted EPS of $7.57 vs. $9.19, a decline of about 18%.
Q4 GAAP diluted EPS of $0.49 vs. $4.36; Q4 adjusted EPS of $1.99 vs. $2.13, including a $118 million pension settlement loss and $30 million investment impairment.
Adjusted Segment EBIT grew to $2,459 million for the year (from $2,335 million) and to $756 million in Q4 (from $546 million), with all four segments reporting higher Q4 adjusted EBIT.
Viterra combination completed: diluted share count rose to 195 million in Q4 from 138 million, diluting per-share results, and Corporate costs rose to $(800) million EBIT from $(626) million.
Operating cash flow fell to $844 million from $1,900 million, while Adjusted FFO was $1,733 million vs. $1,682 million.
Total debt increased substantially, with short-term debt of $3,883 million and long-term debt of $8,831 million, while cash declined to $1,135 million from $3,311 million.
2026 guidance: adjusted EPS of $7.50 to $8.00, with capex of $1.5 to $1.7 billion and net interest expense of $575 to $625 million.

03—Questions

Frequently Asked Questions

Why did GAAP EPS fall so sharply when segment profits rose?
Segment adjusted EBIT rose, but several items weighed on reported results: higher Corporate and Other costs tied largely to the Viterra integration, a $118 million pension settlement loss, a $30 million impairment on long-term investments, a $15 million credit loss reserve, and higher interest expense of $628 million vs. $471 million. The 2025 gain on the corn milling divestiture (about $155 million) partly offset these, but the much larger share count also reduced per-share earnings.
What does the 2026 guidance imply for investors?
Bunge guided to 2026 adjusted EPS of $7.50 to $8.00, which is roughly flat to modestly down from the $7.57 adjusted EPS reported for 2025 at the midpoint of the range. The guidance is based on current margins and forward curves, and management noted that forward visibility remains limited. Investors should watch for synergy targets and capital allocation details at the March 10, 2026 Investor Day.
Why did operating cash flow decline even though Adjusted FFO increased?
Reported operating cash flow fell to $844 million from $1,900 million mainly because of lower reported net income and working capital changes, including higher inventories (up $700 million in cash-flow terms) and receivables. Adjusted FFO excludes working capital changes, FX on net debt, and mark-to-market timing differences, so it rose to $1,733 million, but it is a non-GAAP measure and investors should weigh the reported cash decline.
How has Bunge's balance sheet changed after the Viterra combination?
Total assets rose to $44,528 million from $24,899 million, driven by a larger PP&E base ($11,678 million), inventories ($13,198 million), and goodwill and intangibles ($3,450 million). Total debt increased significantly, and cash declined to $1,135 million. Total equity grew to $17,369 million, partly reflecting the share issuance tied to the combination, and the company's leverage and liquidity position is now materially different from a year ago.
What are the main risks highlighted in this release?
The release flags weather and crop disease, commodity and freight price volatility, trade and tariff policy, biofuels regulation, geopolitical risks including the Ukraine-Russia war and sanctions, execution risk in integrating Viterra and capturing synergies, and foreign exchange. Management also noted that market conditions make near-term visibility limited, and the company refers investors to Item 1A of its 10-K for a fuller discussion.

04—Continue

← View all 8-K filings